Hepatitis C virus (HCV) is the major cause of non-A non-B hepatitis and a leading cause of liver dysfunction worldwide. While the current therapy for chronic HCV infection is parenteral administration of type 1 interferon (IFN), only a fraction of HCV-infected individuals completely respond to treatment. Previous studies have correlated the IFN sensitivity of strain HCV-1b with mutations within a discrete region of the viral nonstructural 5A protein (NS5A), termed the interferon sensitivity determining region (ISDR), suggesting that NS5A may contribute to the IFN-resistant phenotype of HCV. To determine the importance of HCV NS5A and the NS5A ISDR in mediating HCV IFN resistance, we tested whether the NS5A protein could regulate the IFN-induced protein kinase, PKR, a mediator of IFN-induced antiviral resistance and a target of viral and cellular inhibitors. Using multiple approaches, including biochemical, transfection, and yeast genetics analyses, we can now report that NS5A represses PKR through a direct interaction with the protein kinase catalytic domain and that both PKR repression and interaction requires the ISDR. Thus, inactivation of PKR may be one mechanism by which HCV avoids the antiviral effects of IFN. Finally, the inhibition of the PKR protein kinase by NS5A is the first described function for this HCV protein.
INTRODUCTION
nagle, 1994; Iino et al., 1994) . Importantly, type I IFN is currently the only approved therapy for chronic HCV HCV, a member of the Flaviviridae (Kato et al., 1990) , infection (Hoofnagle, 1994; Iino et al., 1994) . is the major cause of non-A non-B hepatitis, increasingly
Response to IFN therapy differs among the six HCV becoming a source of morbidity worldwide (Cuthbert, genotypes, but is observed, at some level, in all HCV 1994; Mansell and Locarnini, 1995) . The HCV virion congenotypes worldwide. Of the two predominant HCV getains a 9.4-kilobase single-stranded positive-sense RNA notypes, HCV-1a and HCV-1b, the former predominates genome which encodes a single polyprotein of approxiin the Americas and Europe while the latter predomimately 3010 amino acids (aa) that is posttranslationally nates throughout most Asian countries; both exhibit a cleaved into individual structural and nonstructural prohigh level of resistance to IFN therapy (Fried and Hoofteins within the infected host cell (Selby et al., 1993; nagle, 1995) . Recently, others have sequenced clinical Shukla et al., 1995; Grakoui et al., 1993) . Chronic HCV isolates of the HCV genome and correlated mutations infection leads to liver cirrhosis in a high frequency of within a discrete region of the nonstructural 5A protein cases and long-term virus persistence is epidemiologi-(NS5A), termed the IFN sensitivity determining region cally associated with the development of hepatocellular (ISDR), of HCV-1b with the IFN-sensitive phenotype carcinoma (Bisceglie, 1995) . The public health impact of (shown in Fig. 1A ). These studies demonstrated that chronic HCV infection is currently being realized. In the strains closely matching the prototype HCV-1b NS5A seUnited States alone approximately 3.5 million individuals quence correlated with complete IFN resistance (Enoare believed to be infected with HCV, reflected in the moto et al., 1995, 1996) . high frequency of adult liver transplants which are indiPrior to the current report, possible mechanisms uncated due to complications from HCV infection (Alter, derlying this HCV resistance to IFN therapy were un-1995). This is underscored by the high proportion of HCVknown. The IFN-induced cellular antiviral response is infected individuals (60-80%) who fail to respond to IFN mediated in part by the actions of the Mx proteins, the therapy or who relapse after therapy cessation (Hoof-2-5 oligoadenylate synthetase, RNAse L, and PKR (review by Sen and Lengyel, 1992; Sen and Ransohoff, 1993) . Induced by IFN, these antiviral effector proteins the most widely studied of all the IFN-induced gene prodand C-terminal coding fragments, each of which lacked the ISDR. The N-terminal region, encoding amino acids ucts is the PKR protein kinase (Meurs et al., 1990) . Activated by binding to double-stranded RNA (dsRNA), in-1-236, was amplified by PCR using primer A and primer C, 5-CCACTCGAGCGGACAGTTGGCTGG (XhoI site cluding viral RNAs and regions of secondary RNA structure, PKR phosphorylates the a subunit of eukaryotic underlined). The C-terminal region, encoding amino acids 278-447, was amplified using primer B and primer translation initiation factor 2 (eIF-2a) resulting in a global cessation of protein synthesis and a concomitant block D, 5-CCGCTCGAGTGGTGATTCTGGTCTC (XhoI site underlined). The resulting PCR products were cloned diin viral replication within the infected cell (Hershey, 1991; Clemens, 1996; Merrick and Hershey, 1996) . To counterrectly into pCR2.1 to yield pN/CR2.1 and pC/CR2.1, respectively. The N-terminal coding region of NS5A was act the deleterious effects of IFN induction and PKR activation, many eukaryotic viruses have evolved mechathen removed from pN/CR2.1 for insertion into pcDNA3.1/ His to generate pcDNA3.1/His-NS5A 1-236. An ISDR denisms to block the activity of PKR, including directing the physical interaction of PKR with specific kinase inhibitory letion construct was prepared by insertion of the C-terminal coding fragment into the XhoI and XbaI sites of molecules (summarized in Fig. 1B) (Katze, 1993 (Katze, , 1995 . Examples include influenza virus which functionally repcDNA3.1/His-NS5A 1-236 to generate pcDNA3.1/His-DISDR. This construct encodes NS5A amino acids 1-cruits the cellular PKR inhibitor, P58
IPK , that binds to PKR to block kinase activity (Gale et al., 1996; Lee et al., 1990, 236 fused in-frame with amino acids 278-447, deleting the entire ISDR. The insert from pcDNA3.1/His-DISDR 1994; Polyak et al., 1996) . The virally encoded vaccinia virus K3L protein, human immunodeficiency virus (HIV), was then subcloned into the 2m yeast expression vectors pBD and pYES2 to give pBD-DISDR and pYES2-DISDR, Tat protein and adenovirus VAI RNA similarly bind to PKR to block kinase activity (Gale et al., 1996; Katze et al., respectively. To obtain the NS5A coding region from HCV-1b, viral RNA was extracted from 100 ml of serum 1987; McMillan et al., 1995; Carroll et al., 1993; Beattie et al., 1991 Beattie et al., , 1995 . (Chomczynski and Sacchi, 1987) obtained under informed consent from a genotype 1b patient who failed The high frequency of IFN-resistant HCV in the human population suggests that HCV, like these many other anito respond to IFN therapy. Response to IFN was determined by RT-PCR and bDNA assay, as previously demal viruses, has evolved a mechanism(s) to block the IFN-mediated response to viral infection. Although the scribed (Gretch et al., 1993) . Verification of HCV genotype was determined by a combination of RFLP and genotypefunction of NS5A and its role in viral replication had been unknown, it has been suggested that NS5A, by an ISDRspecific PCR analyses of the viral 5 untranslated region and sequences encoding the core protein, respectively directed mechanism, may mediate IFN resistance by interacting with and repressing one or more IFN-induced (Davidson et al., 1995; Okamoto et al., 1992) . Viral cDNA was synthesized by reverse transcription using the primantiviral gene products. In the current report, we now provide direct proof that NS5A interacts with and inhibits ing oligonucleotide 5 GTGGTGACGCAGCAGAGAGT (corresponding to nt 7681-7700 of HCV-J (Bukh et al., the IFN induced protein kinase, PKR. Importantly, we found that the ISDR was required for NS5A interaction 1995), followed with first-round PCR by the addition of the upstream primer 5CAGCCTCACCATCACTCAGC with PKR and repression of PKR activity. These data thus provide the first evidence for the molecular mechanisms (corresponding to HCV-J nt 6256-6275). For directional cloning of NS5A, first-round PCR products were further underlying HCV resistance to IFN therapy. amplified using the NS5A-specific nested-set oligonucleotide primer pair 5CCTTCCATGGGCTCCGGCTCGT-
MATERIALS AND METHODS
GGCTAAAG and 5ATCGGATCCTTAGGACATTGAGCA-Plasmid construction GCAGACGA (NcoI and BamHI sites underlined, respectively). After restriction enzyme digestion, the purified To generate wild-type HCV 1a NS5A constructs, the complete NS5A coding region from pSPns5 (HCV-1a; a PCR products were cloned into the corresponding sites of pACT2 (Clontech) to give pAD-NS5A, which encodes generous gift from Dr. C. Seeger) was amplified by PCR using the oligonucleotide primers A, 5-GGAATTCGAGan AD-NS5A fusion protein corresponding to HCV-1b. While the relationship between the ISDR aa sequence CTCGCCCG and B, 5-GCTCTAGAAGCACACGACAT-CTTC (EcoRI and XbaI sites underlined). The resulting of HCV-1a and IFN sensitivity has not been precisely determined, this region of NS5A (aa 237-276) possessed product was directly cloned into pCR2.1 (Invitrogen) to yield plasmid pNS5A/CR2.1 The NS5A coding region was significant aa identity to the prototypic IFN-resistant ISDR sequence defined previously (Enomoto et al., 1995 (Enomoto et al., , 1996 removed from pNS5A/CR2.1 as an EcoRI fragment for insertion into pBD (Stratagene) to yield pBD-NS5A, or as and present in our HCV-1b NS5A clone (Fig. 1A) . Construction of PKR plasmids pBD-PKR K296R, pAD-PKR aa an EcoRI-XbaI fragment for insertion into pcDNA3.1/His and pYES2 (Invitrogen), to give pcDNA3.1/His-NS5A and constructs K296R, 1-242, 244-551, 244-366, 367-551, and pAD-P58 IPK wt were described previously (Gale et al., pYES2-NS5A, respectively. To generate the ISDR deletion mutant of NS5A, we first generated individual N-terminal 1996). pBD-PKR 98-551 was constructed by recovering the 1.6-kb NdeI/BamHI fragment from pET11a-PKR M7 phorylated substrates. We have shown previously that there is a perfect correlation between phosphorylation and cloning it into the corresponding sites of pGBT10 (Gale et al., 1996) . pEMBLYex4-K3L conof histones and purified eIF-2a by PKR in vitro . tains the entire vaccinia virus K3L gene inserted into pEMBLYex4 and is described in a separate paper (M.
Analysis of protein interaction in vivo Kobayashi, E. Locke, J. Silverman, T. Ung, and T. Dever, manuscript submitted for publication). GST-NS5A was For analysis of protein interactions in vivo we emproduced by introducing the BamHI fragment from the ployed the Saccharomyces cerevisiae strain Hf7c ( MATa HCV-1a NS5 clone pSPns5 into the plasmid pGEX2T ura 3-52 his 3-200 lys2-801 ade2-101 trp 1-901 lea2-3,112 (Smith and Johnson, 1988) to give pGST-NS5A. This congal4-542 gal80-538 LYS2::GAL1-HIS3 URA3::(GAL4 17-struct encodes NS5A aa 1-427 fused in frame with the mers) 3 -CYC1-lacZ) in a 2-hybrid assay (Fields and Song, glutathione S-transferase protein. The nt sequences of all 1989). For the 2-hybrid assay and the yeast assays deconstructs used in this study were confirmed by doublescribed below, cells were transfected by the lithium acestranded DNA sequence analysis using an Applied Biotate method with the indicated expression constructs. systems automated sequencer.
For 2-hybrid analysis, we first verified expression of all AD-and BD-fusion proteins in the transfected yeast Analysis of protein interaction in vitro clones by immunoblot analysis, using anti-AD or anti-BD monoclonal antibodies (Clontech) as described by the Escherichia coli harboring pGEX2T or pGST-NS5A were grown in liquid culture and GST or GST-NS5A exmanufacturer. In yeast strain Hf7c, synthesis of histidine is dependent upon interaction of the 2-hybrid proteins. pression was induced by the addition of isopropyl thiogalactopryanoside into the culture medium. Bacteria were Thus in the presence of a 2-hybrid protein interaction strains will exhibit growth on histidine-deficient medium. harvested and extracts prepared for binding analyses as described previously (Gale et al., 1996) . For binding
We thereby used the synthesis of the HIS reporter protein to assay for 2-hybrid protein interaction, as recently deanalyses, we first confirmed expression of GST or GST-NS5A in our recombinant extracts by immunoblot analyscribed (Gale et al., 1996) . Initial transfectants were selected on SD medium lacking the aa Trp and Leu (/His sis using either a GST-specific antiserum or an antiserum specific to a superoxidedismutatse-NS5 fusion protein medium). Transfectants were subsequently streaked onto SD medium lacking the aa His, Trp, and Leu (0His (anti-NS5; Chiron Corp.). Positive recombinant extracts were used for in vitro binding analysis. Wild-type human medium) and were grown for 3-6 days to allow depletion of residual histidine stores. Colonies were restreaked PKR and PKR deletion mutants were in vitro transcribed from the T7 promoter of pcDNA1neo and translated in onto 0His medium and scored for growth after 3-7 days. We confirmed induction of reporter gene expression in the presence of [ 35 S]methionine as described previously . For in vitro binding analyses, approxiour 2-hybrid yeast clones (data not shown) by measuring LacZ expression using a liquid assay and the fluorogenic mately 1 1 10 5 counts of trichloroacetic acid-precipitable material from each translation reaction were added to a substrate 4-methylumbelliferyl-b-D-galactoside (MUG) as described (Cao and Geballe, 1994) . crude E. coli extract containing either GST or GST-NS5A and processed as described (Gale et al., 1996) . Labeled
Yeast growth repression assay for determination of proteins which bound to GST or GST-NS5A were sepa-NS5A and PKR function in vivo rated by SDS-PAGE and visualized by autoradiography of the dried gel.
For determination of NS5A and PKR function in vivo we used S. cerevisiae strain RY1-1 (MATa ura3-52 leu2-In vitro assay of PKR function 3 leu2-112 gcn2D trp1-D63 LEU2::(GAL-CYC1-PKR) 2 which carries two copies of human PKR integrated into For PKR in vitro kinase assays GST and GST-NS5A were purified from E. coli extracts using glutathionethe LEU2 locus, under control of the galactose inducible GAL1-CYC1 promoter (Romano et al., 1995) . When grown agarose affinity chromatography. Native PKR was affinity purified from IFN-treated human 293 cells (Galabru and on inducing medium, this strain exhibits a slow growth phenotype due to the PKR-mediated phosphorylation of Hovanessian, 1987) . The concentration of all purified proteins was assessed by quantitative SDS-PAGE using yeast eIF-2a. Protein expression was verified by immunoblot analysis using either an anti-PKR mAb (Laurent et BSA as a standard. In vitro kinase assays were carried out essentially as described (Tang et al., 1996 (Tang et al., ), except al., 1985 or antisera generated against a recombinant NS5 protein (a-NS5) (a gift from Chiron). Both NS5A and that PKR was preincubated with increasing concentrations of GST or GST-NS5A prior to the addition of histone DISDR constructs were efficiently expressed from the pYes plasmid (data not shown). In addition, we found substrates and [g-32 P]ATP. Kinase reaction products were separated by SDS-PAGE and the dried gel was that coexpression of NS5A or DISDR had no effect on PKR levels which were expressed efficiently to equal subjected to autoradiography for visualization of phos-levels in both transfected strains (data not shown). To assess growth of RY1-1 transfectants, yeast colonies were streaked onto uracil-deficient SD medium and SGAL medium as described by Romano et al. (1995) . Growth was assessed at 3-7 days poststreaking of colonies.
Analysis of NS5A function in mammalian cells
To measure the effect of NS5A upon PKR function in mammalian cells, we used a secreted embryonic alkaline phosphatase (SEAP) reporter assay (Berger et al., 1988) . pcDNA1neo-SEAP and pcDNA3.1/His-NS5A were cotransfected into COS1 cells using the DEAE-dextran/ chloroquin method (Cullen, 1987) . Details of the SEAP (Berger et al., 1988) have been described preregion of NS5A from HCV strains 1a and 1b which were used in this viously by our laboratory (Garfinkel et al., 1993) . Trans- To determine the in vivo phosphorylation state of eIFcated (Katze et al., 1987; Gale et al., 1996) . Also indicated is the NS5A-2a within RY1-1 yeast harboring various expression plasbinding region (this study).
mids, extracts were prepared from the respective strains and subjected to isoelectric focusing and immunoblot analyses as described (Dever et al., 1993) . Proteins (20 by employing NS5A from HCV 1-a (Fig. 1A) to test the mg) were first separated by isoelectric focusing and then ability of NS5A to directly interact with PKR. NS5A, extransferred to a nitrocellulose membrane which was subpressed as a glutathione S-transferase (GST) fusion prosequently probed with a rabbit polyclonal antiserum spetein in E. coli (GST-NS5A), specifically interacted with in cific to yeast eIF-2a. The relative levels of basal-and vitro translated full-length PKR using a GST pull-down PKR-phosphorylated eIF-2a from each extract were assay. As seen in Fig. 2A , PKR aa 244-551 were both quantitated by scanning laser densitometry and are prenecessary and sufficient for complex formation with GSTsented as a percentage of the total eIF-2a in a given NS5A. Thus, recombinant NS5A can specifically form a sample. complex with PKR in vitro which maps to within the protein kinase catalytic domain-inclusive PKR C-terminus. RESULTS NS5A interacts with the PKR protein kinase catalytic NS5A and PKR interact in vitro domain in vivo
To confirm and extend these results in vivo, we carried The mechanism(s) of HCV-mediated IFN resistance remain unknown, due in part to the inability to propagate out NS5A-PKR interaction studies using the yeast 2-hybrid system, scoring for growth on histidine-deficient the virus in cultured cells. However, molecular epidemiologic evidence suggests that NS5A may play a role in medium as a positive 2-hybrid protein interaction. For comparison we included an assessment of the P58 IPKrepressing the antiviral affects of IFN during HCV infection (Enomoto et al., 1995 (Enomoto et al., , 1996 . This led us to investi-PKR interaction described previously (Gale et al., 1996) . We found that full-length NS5A from an IFN-resistant isogate the mechanism of HCV-mediated IFN resistance and the contribution of NS5A toward establishing the late of strain HCV-1b fused to the GAL4 activation domain (AD-NS5A) specifically interacted with the inactive full-IFN-resistant phenotype of HCV. We tested the hypothesis that HCV NS5A may possess functions similar to length PKR mutant, PKR K296R, and the truncated mutant PKR 98-551, each of which were fused to the GAL4 DNA those of other viral inhibitors of the IFN response (Katze, 1993 (Katze, , 1995 , directly repressing the activity of PKR binding domain (BD) (Fig. 2B) . BD-PKR 98-551 lacks the first dsRNA binding domain (Fig. 1B) and is deficient in through a physical interaction with the kinase. We began . Transfected yeast were streaked onto /His (top) and 0His medium (bottom). Growth on 0His is indicative of 2-hybrid protein interaction. (C) NS5A from HCV-1a interacts with the PKR protein kinase catalytic domain. Yeasts expressing either the BD alone (BD-vector) or a BD-NS5A fusion protein from HCV-1a (BD-NS5A) were cotransfected with plasmids expressing the indicated AD-PKR fusion constructs or the control AD-vector (bottom row), replica plated onto /His (left) and 0His medium (right) and assayed for growth.
binding dsRNA . Thus, similar to the We next tested the ability of BD-NS5A, from an HCV1a isolate, to interact with AD-PKR in vivo using the 2-cellular PKR inhibitor, P58
IPK , HCV-1b NS5A can physically interact with PKR in vivo. Furthermore, these results hybrid assay. As seen in Fig. 2C , BD-NS5A from HCV 1a specifically interacted with AD-PKR K296R in yeast indicate that the NS5A-PKR interaction is not a dsRNAmediated event.
cotransfectants, as determined by growth in 0His me-dium. Thus, NS5A from the independent strains HCV-1a inhibit the function of PKR in vitro, likely through a direct effect of the NS5A-PKR interaction. and HCV-1b can physically interact with PKR in vivo. To map the NS5A-interactive region of PKR, we employed a Expression of PKR in yeast provides an in vivo functional assay for direct measurement of PKR activity series of AD-PKR mutants to transfect yeast harboring the HCV 1a BD-NS5A construct. BD-NS5A specifically (Romano et al., 1995) . Through its eIF-2a phosphorylating activity, PKR is growth suppressive when exinteracted with the PKR catalytic domain, mapping to within PKR aa 244-366, as AD-constructs PKR 244-pressed in yeast. Coexpression of PKR with transdominant inhibitory PKR mutants or virally encoded PKR 551 and PKR 244-366 both mediated growth on 0His medium (Fig. 2C) (Fig. 1B) (Gale et al., 1996) . This under control of the GAL1 galactose-inducible promoter in yeast strain RY1-1, developed by Romano et region of the protein kinase catalytic domain functions cooperatively in nucleotide binding and catalysis (Hanks al. (1995) . RY1-1 possesses two integrated copies of human PKR under control of the GAL1-CYC1 galactoseet Bossemeyer, 1995; Taylor et al., 1993) . Thus, similar to the proposed mechanisms of P58 IPK -mediated inducible promoter and maintains a PKR-mediated growth-suppressive phenotype when grown on galacinhibition of PKR (Gale et al., 1996) , formation of an NS5A-PKR complex may interfere with kinase activation tose medium. For comparison, we included a parallel analysis of RY1-1 harboring the well-characterized vacto render PKR nonfunctional. cinia virus PKR inhibitor, K3L, also under control of the GAL1-CYC1 promoter (M. Kobayashi, E. Locke, J.
NS5A represses PKR function
Silverman, T. Ung and T. Dever, manuscript submitted for publication). We began our examination of NS5A Inhibition of PKR function is critical for establishment of viral infection. A common theme shared among the function by determining the growth properties of the RY1-1 transfectants. While all transfectants maintained divergent family of virally encoded PKR inhibitors and the cellular inhibitor, P58
IPK , is that inhibition of PKR function efficient growth on noninducing dextrose (SD) medium (Fig. 3B, left) , only those harboring NS5A or K3L were is mediated through a direct physical interaction with the kinase (reviewed by Katze, 1993 Katze, , 1995 . We sought to able to sustain growth under conditions of PKR expression (Fig. 3B, right) . Vector control transfectants exhibdetermine if the NS5A-PKR interaction could similarly result in an inhibition of PKR function. We first carried ited a severe slow growth phenotype consistent with the growth suppressive activity associated with high out an in vitro analysis of PKR activity in the presence of recombinant NS5A. Incubation of purified native PKR with levels of PKR expression (Fig. 3B ) (Romano et al., 1995) . These results demonstrate that NS5A is sufficient to recombinant GST-NS5A from HCV-1a resulted in the specific inhibition of both PKR autophosphorylation and reverse PKR-mediated growth suppression in yeast, indicating that NS5A can directly repress PKR function phosphorylation of an exogenous histone substrate (Fig.  3A) . It is worth noting that as little as 0.2 pmol of NS5A in vivo. To confirm that PKR function was repressed in the presence of NS5A, we determined the level of eIFcan inhibit 1.8 pmol of PKR. At present we cannot determine whether this results from a relatively small percent2a phosphorylation in the RY1-1 transfectants. Similar to K3L, expression of NS5A resulted in approximately age of PKR being active or whether NS5A may function at low levels due, perhaps, to disruption of higher order an 11-fold increase in the level of unphosphorylated eIF-2a over that observed in control transfectants har-PKR dimers. We confirmed that the loss of PKR activity was not due to degradation of PKR or NS5A-mediated boring the vector alone (Fig. 3C) . While the majority of the eIF-2a in these cells remained in the hyperphoshydrolysis of ATP (data not shown). Furthermore, while it is possible that the inhibition of PKR and histone phosphorylated state, these results suggest that relatively small changes in the overall level of eIF-2a phosphoryphorylation in our in vitro assay could be due to a GST-NS5A-mediated phosphatase activity, we believe this to lation can nevertheless have dramatic effects on cell growth. Taken together, these observations indicate be unlikely since NS5A does not possess any structural attributes indicative of phosphatase function. Equal mothat NS5A, through a direct interaction with PKR, can repress PKR function in vivo, resulting in alterations lar levels of GST had no effect upon PKR activity (Fig.  3A, lanes 6-9) . Thus, similar to the action of other virally in the phosphorylation state of the PKR substrate, eIF-2a. encoded PKR inhibitory proteins, NS5A can specifically Purified native PKR (1.8 pmol) was preincubated with buffer (lane 1) or increasing amounts of recombinant purified GST-NS5A (HCV 1a, lanes 2 -5) or GST (lanes 6 -9) and assayed for in vitro kinase activity in the presence of histone H2a substrate. After termination of kinase reactions, phosphorylated products were separated by 12.5% SDS -PAGE and visualized by autoradiography of the dried gel. Arrows indicate the positions of PKR and histones. The molar amounts of input GST-NS5A or GST proteins were 0.2 pmol (lanes 2 and 6), 0.4 pmol (lanes 3 and 7), 0.8 pmol (lanes 4 and 8), and 1.2 pmol (lanes 5 and 9). (B) NS5A reverses PKR-mediated growth suppression in yeast. Yeast strain RY1-1 was transfected with the 2m yeast expression constructs pYES2-NS5A (NS5A; from HCV-1a) or pEMBLYex4-K3L (vaccinia virus K3L; positive control) or the negative control vectors pEMBLYex4 (pYex) and pYes2 (pYes). Transfectants were streaked onto minimal synthetic medium containing 2% dextrose (SD, left) or 10% galactose/2% raffinose (SGAL, right) as the carbon source and scored for growth. SGAL plate represents 5 days of growth. (C) eIF-2a phosphorylation analysis. Extracts from RY1-1 yeast harboring the vector control plasmid pYes2 (lane 1), NS5A (lane 2), or K3L (control; lane 3) were separated by isoelectric focusing and subjected to immunoblot analysis with an antiserum to yeast eIF-2a. Arrows indicate the positions of eIF-2a phosphorylated on basal sites only (lower band) and eIF-2a phosphorylated on Ser 51, the site of phosphorylation by PKR (upper band). The levels of basally phosphorylated eIF-2a relative to total were quantitated by scanning laser densitometry and are: vector, 0.9%; NS5A, 11.2%; and K3L, 11.7%. (D) NS5A stimulates protein synthesis in mammalian cells. COS1 cells expressing the SEAP reporter protein were cotransfected with 10 mg of the control vector, pcDNA3.1/His (vector), or 10 mg plasmid DNA containing pcDNA3.1/His and titrating amounts (indicated in mg) of pcDNA3.1/His-NS5A. SEAP activity was measured from the supernatant of each transfection culture and is shown as the percentage of SEAP activity relative to that of control cells harboring the vector alone, which was normalized to 100%. (Bottom) Expression of NS5A from COS1 cells transfected with vector DNA (vector) or 1, 2, 4, and 6 mg of pcDNA3.1/His-NS5A, as detected by immunoblot analysis using a-NS5 sera. Each lane represents 50 mg of extract electrophoresed from 10 6 cells.
We next sought to determine if NS5A could similarly of protein synthesis in mammalian cells, we tested the ability of NS5A to stimulate protein synthesis in regulate PKR within mammalian cells. Through repression of the eIF-2a-phosphorylating activity of PKR, trantransfected COS1 cells using a secreted embryonic alkaline phosphatase (SEAP) reporter assay (Berger et sient inhibition of PKR in mammalian cells results in a net increase in the level of protein synthesis. Reflecting al., 1988) . Coexpression of SEAP and NS5A (HCV-1a) in COS1 cells resulted in greater than a 300% stimulathis effect of PKR inhibition, negative regulators of PKR can stimulate protein synthesis above basal levels tion of protein synthesis over SEAP/vector cotransfectants (Fig. 3D) (Fig. 1A) ; or BD-vector (bottom row). Both NS5A constructs were derived from HCV-1a. Transfected yeast were replica plated onto /His (left panel) and 0His medium (right) and assayed for growth as described under Materials and Methods. Two-hybrid protein interaction was defined as specific growth on 0His medium. (B) Expression of NS5A GAL4-fusion constructs. Extracts from COS1 cells transfected with pcDNA3.1/His-NS5A (NS5A control; lane 1) or yeast cells with pBD (BD-vector; lane 2), pBD-DISDR (DISDR; lane 3), or pBD-NS5A (BD-NS5A; lane 4) were subjected to immunoblot analysis using a-NS5 sera. (Bottom) The corresponding expression of yeast superoxide dismutase (SOD) using a-SOD sera as determined from the same blot and included to control for variations in extract protein concentrations. By this method we determined that both BD-DISDR and BD-NS5A were expressed to the same levels. The apparent differences seen on the blot reflect a threefold difference in protein concentration between the two extracts. Gel standards are shown in kDa. (C) The ISDR of NS5A is required for reversal of PKR-mediated growth suppression in yeast. Yeast strain RY1-1 harboring the expression constructs pYES2-NS5A (NS5A), pYES2-DISDR (DISDR) or the negative control vector pYES2 (pYes), were streaked onto inducing medium containing 10% galactose/2% raffinose (SGAL) and scored for growth. SGAL plate shown represents 6 days of growth. All transfectants grew when streaked onto noninducing SD medium (data not shown).
and Shatkin, 1989; Tang et al., 1996) , NS5A can stimuwhich similarly lack the ISDR, failed to interact with PKR in this assay (data not shown). In contrast, BD-NS5A late protein synthesis in mammalian cells, likely through a direct inhibitory effect upon PKR.
specifically interacted with AD-PKR K296R (Fig. 4A) . Deletion of the ISDR from NS5A could conceivably render the The NS5A ISDR is required for interaction with PKR mutant protein unstable and unavailable to interact with and repression of PKR function in vivo PKR. However, immunoblot analysis demonstrated that both BD-NS5A and -DISDR constructs were efficiently Inhibition of PKR in infected mammalian cells may be expressed in yeast transfectants (Fig. 4B) . By standardizone mechanism by which HCV mediates resistance to ing protein loading, using antibody to yeast superoxide IFN. Correlation of IFN sensitivity with mutations within dismutase, we quantified NS5A levels and determined the ISDR of NS5A suggested that the ISDR may play a that both BD-DISDR and BD-NS5A were expressed to role in mediating the IFN-resistant phenotype of HCV. A approximately the same levels (see the legend to Fig. key question remaining was whether or not the ISDR 4B). The possibility remains, however, that deletion of contributed to the ability of NS5A to bind to and inhibit the ISDR may render NS5A conformationally constrained, PKR. To begin to determine the requirement for the ISDR thus precluding interaction with PKR. Collectively, these in the NS5A-PKR interaction, we compared the ability of results suggest that the ISDR of NS5A is necessary for BD-NS5A and of a BD-NS5A ISDR-deletion mutant deinteraction with PKR and that deletion of the ISDR may rived from HCV-1a (BD-DISDR; Fig. 1A ) to bind to ADrender NS5A nonfunctional in vivo. We thereby compared PKR K296R in vivo. BD-DISDR failed to mediate interacthe ability of NS5A and the DISDR mutant to reverse the tion with AD-PKR K296R in the yeast 2-hybrid assay (Fig.  4A) . We also found that the N-terminal 236 aa of NS5A, PKR-mediated slow growth phenotype in yeast. Coex-pression of DISDR with PKR in yeast strain RY1-1 failed of NS5A. It is tempting to speculate that specific mutations in the ISDR, which may exist within an HCV quasito reverse PKR-mediated growth repression while expression of NS5A specifically restored growth in the species population, may compromise the ability of NS5A to repress PKR. Though beyond the scope of the transfected yeast clones (Fig. 4C) . These results, taken together, indicate that the NS5A ISDR is required for current report, a broader analysis of NS5A proteins from IFN-resistant and IFN-sensitive HCV strains is interaction with and inhibition of PKR activity in vivo.
required to correlate ISDR structure with the ability to repress PKR. NS5A from both HCV-1a and -1b pos-DISCUSSION sessed the ability to bind to PKR, suggesting the possibility that PKR regulation may be a common mechaThe cellular IFN response is one of the body's first defense mechanisms to prevent the establishment of vinism by which both genotypes may mediate IFN resistance. This is supported by the high response rate to ral infection (Sen and Lengyel, 1992; Sen and Ransohoff, 1993) . The ability of a given animal virus to establish a IFN therapy exhibited in HCV genotypes 2 -4, which lack a consensus ISDR (S. Polyak and D. Gretch, unproductive infection depends in part on the ability of the virus to circumvent the IFN response, which includes the published observations). We suggest that combinatorial therapeutic strategies designed to block the transcriptional induction and functional activation of PKR. Indeed, we have found in many cases that the ability of NS5A -PKR interaction may increase the efficacy of IFN treatment of an HCV-1a or -1b infection. a virus to establish a productive infection correlates well with its ability to repress PKR function (Katze, 1993 (Katze, , 1995 .
We have shown that HCV NS5A from both IFN-resistant HCV-1a and HCV-1b strains can specifically interact Results presented in this study demonstrate that HCV similarly encodes a mechanism to repress PKR. We prowith and inhibit the activity of PKR, also raising the possibility that NS5A could be a PKR substrate. However, our pose that the HCV NS5A protein functions to directly repress PKR, thus preventing, at least in part, the antiviral preliminary results argue against this as we have not found that PKR can phosphorylate NS5A in our in vitro effects of IFN on HCV replication.
In addition to its antiviral properties, PKR plays a funcassay. Moreover, while NS5A does reside in the cell as a phosphoprotein (Tanji et al., 1995; Kaneko et al., 1994) , tional role in signal transduction pathways leading to the transcriptional regulation of gene expression and the we currently do not know what role, if any, that NS5A phosphorylation plays in mediating NS5A function or ininduction of apoptosis (reviewed by Proud, 1995) . Thus, inhibitors of PKR can have profound effects on gene exteraction with PKR. Importantly, NS5A binds to a region of PKR (aa 244-366; Fig 1B) which participates in the pression which may ultimately be detrimental to the cell. Indeed, previous studies from our laboratory and others formation of active PKR dimers (Patel et al., 1995) . This region includes a regulatory autophosphorylation site, Thave shown that inhibitors of PKR can induce oncogenesis (Koromilas et al., 1992; Meurs et al., 1993; 258, followed by protein kinase catalytic domain conservation regions I-V (Taylor et al., 1996; Hanks et al., 1988 Hanks et al., ). al., 1995 . While other mechanisms of oncogenesis may exist within an HCV-infected cell, including those specific Based upon the known crystal structure of the catalytic domain of related protein kinases, NS5A would occupy to the transforming properties of the NS3 and viral core proteins (Sakamuro et al., 1995; Ray et al., 1996) , it is a critical region within the small lobe and catalytic cleft of the PKR catalytic domain that is involved in nucleotide tempting to speculate that the NS5A-mediated inhibition of PKR may lead to malignant transformation of the inbinding and catalysis (Bossemeyer, 1995; Taylor et al., 1993) . Significantly, among various protein kinases this fected hepatocyte, perhaps reflecting the high frequency of hepatocellular carcinomas within the HCV-infected region of the catalytic domain appears to be the target for interaction by kinase-regulatory proteins, including population.
Molecular epidemiological studies have revealed that between the cyclic AMP-dependent protein kinase and its RI regulatory subunit, as well as the cyclin/cyclinthat the HCV genome exhibits a significant level of heterogeneity within HCV infected individuals as a redependent kinase interactions (reviewed in Bossemeyer, 1995; Taylor et al., 1993) . Unlike the vaccinia virus K3L sult of the high frequency of mutations that occur during viral replication (Bukh et al., 1995) . Referred to as and adenovirus VAI gene products, which inhibit PKR by functioning as a pseudosubstrate and competitive inhibiviral quasispecies, the population of HCV genomes within an infected individual may influence the outtor of activator-dsRNA binding, respectively (Katze, 1993 (Katze, , 1995 , we propose that NS5A may interfere with events come of IFN therapy. Indeed, this is supported by the recent studies which correlate mutations in the ISDR leading to activation and catalysis by directly interfering with dimerization, autophosphorylation, and/or steps of the HCV-1b NS5A protein with IFN sensitivity (Enomoto et al., 1995 (Enomoto et al., , 1996 . Importantly, our data have within the catalytic process. It is worth noting that the NS5A-interactive region of PKR includes the domain indicated that the ISDR was required for both PKR binding and functional PKR repression, possibly defining a which binds the cellular PKR inhibitor, P58 IPK (Fig. 1B)  (Gale et al., 1996) . The localization of both the P58 IPKcritical role for this region in mediating in vivo function sequences amplified from the 5 non-coding region. J. Gen. Virol. 76,  and the NS5A-interactive sites to overlapping domains 1197-1204. of PKR reflects the importance of this region for kinase Dever, T. E., Chen, J. J., Barber, G. N., Cigan, A. M., Feng, L., Donahue, function and suggests that these divergent inhibitors may T. F., London, I. M., Katze, M. G., and Hinnebusch, A. G. (1993 
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